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SUPPLEMENTARY APPENDIX 
Supplementary Table 1: Liver-related primary ICD-10 diagnosis codes 
Hospitalisations with the primary ICD-10 diagnosis codes listed below were classified as liver-
related.  
Primary ICD-10 code Description 
K70     Alcoholic liver disease 
K70.0  Alcoholic fatty liver 
K70.1  Alcoholic hepatitis 
K70.2  Alcoholic fibrosis and sclerosis of liver 
K70.3  Alcoholic cirrhosis of liver 
K70.4  Alcoholic hepatic failure 
K70.9  Alcoholic liver disease, unspecified 
K71.8  Toxic liver disease with other disorders of liver 
K72     Hepatic failure, not elsewhere classified 
K72.0  Acute and subacute hepatic failure 
K72.1  Chronic hepatic failure 
K72.9  Hepatic failure, unspecified 
K74.6  Other and unspecified cirrhosis of liver 
K75.8  Other specified inflammatory liver diseases 
K76.0  Fatty (change of) liver, not elsewhere classified 
K76.5  Hepatic veno-occlusive disease 
K76.6  Portal hypertension 
K76.7 Hepato-renal syndrome 
K76.9  Liver disease, unspecified 
C22.0  Malignant neoplasm: Liver cell carcinoma 
I85      Oesophageal varices 
I85.0   Oesophageal varices with bleeding 
I85.9   Oesophageal varices without bleeding 
















Supplementary Table 2: Additional (potentially liver-related) primary ICD-10 diagnosis codes  
For hospitalisations with the primary ICD-10 diagnosis codes listed below, anonymised records 
were reviewed on a case-by-case basis by a medical representative of the study sponsor to 
determine whether the admission was liver-related. 
Primary ICD-10 code Description 
R18     Ascites 
R41.0  Disorientation, unspecified 
R41     
Other symptoms and signs involving cognitive 
functions and awareness 
F10.0  
Mental and behavioural disorders due to use of 
alcohol: Acute intoxication 
G93.4  Encephalopathy, unspecified 
F10.3  
Mental and behavioural disorders due to use of 
alcohol: Withdrawal state 
F05.9  Delirium, unspecified 
I98.2   
Oesophageal varices without bleeding in diseases 
classified elsewhere 
I98.3   




Supplementary Table 3: All-cause resource use in surviving patients prescribed rifaximin-α 
1100mg/day (UK licensed dose) 
 6 months (N=114) 12 months (N=102) 















ALL-CAUSE RESOURCE USE 
























Definitions: ‘Hospitalisation’ includes overnight stay admissions only (i.e. excluding day case); it includes both non-elective 
(unplanned) admissions (via ED or GP direct referral route) and elective (planned) admissions.  
Abbreviations: ED, emergency department; GP, general practitioner; RFX, rifaximin-α. 
 
* Data are presented for all surviving patients at the end of 6 months (N=114) or 12 months (N=102) 
#  
Number of patients with ≥ 1 admission/attendance in the observed periods (pre-RFX, post-RFX or both) 
†
 




Supplementary Table 4: Resource use in surviving patients with at least one admission / 
attendance in the observed periods (pre-rifaximin-α, post-rifaximin-α or both) 
 6 months  12 months 















LIVER-RELATED RESOURCE USE 



























































































All-CAUSE RESOURCE USE 








































































































Definitions: ‘Hospitalisation’ includes overnight stay admissions only (i.e. excluding day case); it includes both non-elective 
(unplanned) admissions (via ED or GP direct referral route) and elective (planned) admissions. ‘ED attendance’ includes only 
attendances which did NOT result in hospital admission.  
Abbreviations: ED, emergency department; GP, general practitioner; RFX, rifaximin-α. 
 
* Data are presented for surviving patients with ≥ 1 admission/attendance in the pre-RFX, post-RFX or both periods 
#  
Number of surviving patients with ≥ 1 admission/attendance in the observed periods (pre-RFX, post-RFX or both) 
†
 




Data only available for all-cause (not liver-related) 
  
SUPPLEMENTARY FIGURE LEGENDS 
 
Supplementary Figure 1: Critical care admissions and bed days in surviving patients 
 
Panel A: Liver-related  
 
Panel B: All-cause  
 
